Green Thumb Industries (GTBIF) Gains from Investment Securities (2020 - 2026)
Green Thumb Industries (GTBIF) posted Gains from Investment Securities of $1.1 million for Q1 2026, up 53.49% on a QoQ basis from $731000.0 in Q1 2023.
Green Thumb Industries (GTBIF) Gains from Investment Securities (2020 - 2026) Analysis & Trends
Green Thumb Industries' Gains from Investment Securities history runs 5 years deep, the most recent figure standing at $1.1 million for Q1 2026.
- Quarterly Gains from Investment Securities changed N/A year-over-year to $1.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.6 million (up 25.18% YoY) and the FY2025 annual result came in at -$125.9 million, changed N/A from the prior year.
- Gains from Investment Securities was $1.1 million for Q1 2026 at Green Thumb Industries, up from $731000.0 in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $2.8 million in Q4 2022 and bottomed at -$16.6 million in Q2 2022.
- A 3-year average of -$4.5 million and a median of $461000.0 in 2022 frame the typical range for Gains from Investment Securities.
- Peak annual rise in Gains from Investment Securities reached 131.06% in 2022, while the deepest fall reached 3827.85% in 2022.
- Green Thumb Industries' Gains from Investment Securities stood at $2.8 million in 2022, then slumped by 73.66% to $731000.0 in 2023, then surged by 53.49% to $1.1 million in 2026.
- Business Quant data shows GTBIF's Gains from Investment Securities at $1.1 million in Q1 2026, $731000.0 in Q1 2023, and $2.8 million in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn |
| 10 | Green Thumb Industries | 1.63 Bn | 1.29 Bn | 143.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.12 Mn |
| Mar 31, 2026 | 1.12 Mn |
| Mar 31, 2023 | 731,000.00 |
| Mar 31, 2023 | 731,000.00 |
| Dec 31, 2022 | 2.78 Mn |
| Dec 31, 2022 | 2.78 Mn |
| Sep 30, 2022 | 191,000.00 |
| Sep 30, 2022 | 191,000.00 |
| Jun 30, 2022 | -16.58 Mn |
| Jun 30, 2022 | -16.58 Mn |
| Mar 31, 2022 | -15.40 Mn |
| Mar 31, 2022 | -15.40 Mn |
| Dec 31, 2021 | -8.94 Mn |
| Dec 31, 2021 | -8.94 Mn |
| Sep 30, 2021 | 249,000.00 |
| Sep 30, 2021 | 249,000.00 |
| Mar 31, 2021 | 413,000.00 |
| Mar 31, 2021 | 413,000.00 |
| Dec 31, 2020 | -8.22 Mn |
| Dec 31, 2020 | -8.22 Mn |